|
|
| (114 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| | + | |
| | | | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| | + | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| | + | *'''[[Clinical guidelines and advice]]''' |
| | | | |
| | | | |
| − | *'''[[Clinical guidelines and advice]]'''
| |
| − | {{tp|p=32353109|t=ä. COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy |pdf=|usr=}}
| |
| − | {{tp|p=32343984|t=ä. COVID-19: before stopping specific infection control measures, be sure to exclude the diagnosis |pdf=|usr=}}
| |
| − | {{tp|p=32201156|t=ä. Multiple parameters required for diagnosis of COVID-19 in clinical practice |pdf=|usr=}}
| |
| − | {{tp|p=32340895|t=ä. Less is More: Intelligent Intensive Care for SARS-CoV-2 Based on the Imaging Data |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Respiration mgmt]]''' |
| | | | |
| | + | *'''[[Diagnosis (Laboratory)]]''' |
| | | | |
| | | | |
| | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| | | | |
| − | ----
| + | *'''[[Diagnosis (other modalities)]]''' |
| | | | |
| | | | |
| − | *'''[[Structure of covid19]]'''
| |
| | | | |
| − | *'''[[Target binding and uptake]]'''
| |
| | | | |
| | + | *'''[[Structure of covid19]]''' |
| | | | |
| | | | |
| | + | *'''[[Target binding and uptake]]''' |
| | *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
| − |
| |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
| | | | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| − | {{tp|p=31981224|t=2020. Coronavirus infections and immune responses |pdf=|usr=}}
| |
| − | {{tp|p=32198005|t=2020. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| | | | |
| − | ----
| |
| | | | |
| | | | |
| | + | *'''[[Pathobiology]]''' |
| | | | |
| | | | |
| − | *'''[[Early symptoms]]''' | + | *'''[[Disease Models]]''' |
| | | | |
| − | *'''[[Systemic disease, any manifestations]]'''
| |
| | | | |
| − | *'''[[Co-Infection]]''' | + | *'''[[Similar diseases and pathomechanisms]]''' |
| | | | |
| − | *'''[[ARDS]]'''
| |
| | | | |
| − | *'''[[Pulmonary embolism, coagulation]]'''
| |
| − | {{tp|p=32311448|t=ä. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Hematology]]'''
| |
| | | | |
| − | *'''[[Microvascular]]''' | + | *'''[[Early symptoms]]''' |
| | | | |
| − | *'''[[Heart]]''' | + | *'''[[Systemic disease, any manifestations]]''' |
| − | {{tp|p=32209382|t=ä. The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease |pdf=|usr=}}
| + | |
| − | {{tp|p=32370558|t=2020. Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[Co-Infection]]''' |
| | | | |
| − | *'''[[Neurology, ophthalmology, orl]]'''
| |
| − | *'''[[Dermatology]]'''
| |
| | | | |
| − | *'''[[Gastroenterology, hepatology]]''' | + | *'''[[Pulmonary embolism, coagulation]]''' |
| − | {{tp|p=32363540|t=ä. Bowel Necrosis in the Setting of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32298767|t=ä. COVID-19: Abnormal liver function tests |pdf=|usr=}}
| + | |
| − | {{tp|p=32249184|t=ä. Can COVID-19 present unusual GI symptoms?|pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[Kidney, urology]]'''
| |
| | | | |
| − | ----
| |
| | | | |
| | | | |
| − | *'''[[Pathobiology]]'''
| |
| | | | |
| | + | *'''[[Hematology]]''' |
| | | | |
| − | *'''[[Disease Models]]'''
| |
| | | | |
| − | *'''[[Similar diseases and pathomechanisms]]'''
| |
| − | ----
| |
| | | | |
| | + | *'''[[Heart]]''' |
| | | | |
| − | *'''[[Diagnosis (Laboratory)]]'''
| |
| − | {{tp|p=32031264|t=2020. Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring |pdf=|usr=}}
| |
| − | {{ttp|p=31944312|t=2020. Recent advances in the detection of respiratory virus infection in humans |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Diagnosis (Lung CT, Sonography)]]''' | + | *'''[[Neurology, ophthalmology, orl]]''' |
| − | {{tp|p=32279977|t=ä. What We Know So Far (As of March 26, 2020) About COVID-19 ? An MRT Point of View |pdf=|usr=}}
| + | |
| − | {{tp|p=32328927|t=2020. (J Med Ultrasound) COVID-19 |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| − | *'''[[Diagnosis (other modalities)]]''' | + | *'''[[Dermatology]]''' |
| − | {{tp|p=32344326|t=2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Respiration mgmt]]'''
| |
| | | | |
| | + | *'''[[Gastroenterology, hepatology]]''' |
| | | | |
| − | *'''[[Risk and special populations]]''' | + | *'''[[Kidney, urology]]''' |
| − | {{tp|p=32305459|t=2020. Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report |pdf=|usr=}}
| + | |
| − | {{tp|p=32198004|t=ä. A Patient with SARS-CoV-2 Infection during Pregnancy in Qingdao, China |pdf=|usr=}}
| + | |
| − | {{tp|p=32147409|t=ä. Are children less susceptible to COVID-19?|pdf=|usr=}}
| + | |
| − | | + | |
| | | | |
| | *'''[[The morbid survivor]]''' | | *'''[[The morbid survivor]]''' |
| − | {{tp|p=32334770|t=2020. The Need to Include Assisted Living in Responding to the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32222763|t=ä. COVID-19 Through the Lens of Gerontology |pdf=|usr=}}
| |
| − | {{tp|p=32305489|t=ä. Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Risk and special populations]]''' |
| | | | |
| | | | |
| | | | |
| | *'''[[Case reports]]''' | | *'''[[Case reports]]''' |
| − | {{tp|p=32193905|t=2020. First Pediatric Case of Coronavirus Disease 2019 in Korea |pdf=|usr=}}
| + | |
| − | {{tp|p=32080990|t=2020. Virus Isolation from the First Patient with SARS-CoV-2 in Korea |pdf=|usr=}}
| + | |
| − | {{tp|p=32030925|t=2020. The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures |pdf=|usr=}}
| + | |
| − | {{tp|p=32073161|t=2020. The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019 |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| | *'''[[Case series]]''' | | *'''[[Case series]]''' |
| − | {{tp|p=32233161|t=2020. Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32242348|t=2020. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19 |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Registries]]''' | | *'''[[Registries]]''' |
| − | {{tp|p=32305438|t=ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| − | {{tp|p=32290293|t=2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − |
| |
| − | ----
| |
| − |
| |
| − | *'''[[Remission, recurrence and persistence]]'''
| |
| − |
| |
| | | | |
| | | | |
| | *'''[[Other routes of infection]]''' | | *'''[[Other routes of infection]]''' |
| − | {{tp|p=32276848|t=ä. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32224116|t=ä. Do children need a longer time to shed SARS-CoV-2 in stool than adults?|pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Biophysics of aerosols]]''' | | *'''[[Biophysics of aerosols]]''' |
| − | {{tp|p=32340347|t=2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough |pdf=|usr=}}
| + | |
| − | {{tp|p=32360356|t=ä. Putting some context to the aerosolization debate around SARS-CoV-2 |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
| | + | |
| | | | |
| | | | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − | {{tp|p=32259628|t=ä. Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist |pdf=|usr=}}
| |
| − | {{tp|p=32208139|t=ä. Coronavirus Disease 2019 (COVID-19) and Beyond: Micropractices for Burnout Prevention and Emotional Wellness |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| | | | |
| | | | |
| − | *'''[[Socio-psychiatric aspects of the status hygienicus]]'''
| |
| | | | |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| − | {{tp|p=32283124|t=ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| − | {{tp|p=32147406|t=ä. Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China |pdf=|usr=}}
| + | |
| − | {{tp|p=32243947|t=ä. Beyond the assistance: additional exposure situations to COVID-19 for healthcare workers |pdf=|usr=}}
| + | |
| − | {{tp|p=32278703|t=ä. Preventing the Transmission of COVID-19 Amongst Healthcare Workers |pdf=|usr=}}
| + | |
| − | {{tp|p=32278701|t=ä. Knowledge, attitude and practice regarding COVID-19 among health care workers in Henan, China |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=32325710|t=2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response |pdf=|usr=}}
| |
| − | {{tp|p=32305533|t=ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review |pdf=|usr=}}
| |
| − | {{tp|p=32292707|t=ä. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns |pdf=|usr=}}
| |
| − | {{tp|p=32048740|t=2020. Economic impacts of Wuhan 2019?nCoV on China and the world |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 199: |
Zeile 145: |
| | | | |
| | *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| − | {{tp|p=31967321|t=2020. Cross?species transmission of the newly identified coronavirus 2019?nCoV |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| − | {{tp|p=32277970|t=ä. Strategies to trace back the origin of COVID-19 |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Epidemiology]]''' |
| | | | |
| | | | |
| − | *'''[[Epidemiology]]'''
| |
| | | | |
| | | | |
| | + | |
| | + | *'''[[Remission, recurrence and persistence]]''' |
| | | | |
| | | | |
| − | *'''[[Failure of politics and public health guidance]]'''
| |
| − | {{tp|p=32373315|t=ä. The need to improve the laws and regulations relevant to the outbreak of COVID-19: What might be learned from China?|pdf=|usr=}}
| |
| − | {{tp|p=32302966|t=2020. Health Communication Through News Media During the Early Stage of the COVID-19 Outbreak in China: Digital Topic Modeling Approach |pdf=|usr=}}
| |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | ---- | | ---- |
| | + | *'''[[Failure of politics and public health guidance]]''' |
| | | | |
| | | | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
| − | {{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32271208|t=ä. Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People?s Republic of China |pdf=|usr=}}
| |
| − | {{tp|p=32277966|t=ä. Characteristics of deaths amongst health workers in China during the outbreak of COVID-19 infection |pdf=|usr=}}
| |
| | | | |
| | *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| | + | |
| | ---- | | ---- |
| | | | |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | {{tp|p=32120913|t=2020. Epidemiological Identification of A Novel Pathogen in Real Time: Analysis of the Atypical Pneumonia Outbreak in Wuhan, China, 2019?2020 |pdf=|usr=}}
| + | *'''[[misc.]]''' |
| − | {{tp|p=32001309|t=2020. Emergence of a novel coronavirus causing respiratory illness from Wuhan, China |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[misc.]]''' | + | *'''[[Research tools]]''' |
| − | {{tp|p=32277235|t=ä. My Future in Medicine: How COVID-19 Is Inspiring the Next Generation of Infectious Disease Specialists |pdf=|usr=}}
| + | |
| − | {{tp|p=32229647|t=2020. COVID-19: An Unintended Force for Medical Revolution?|pdf=|usr=}}
| + | |
| − | {{tp|p=32332154|t=2020. Balancing the duty to treat with the duty to family in the context of the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32293580|t=2020. Global Reach of an Online COVID-19 Course in Multiple Languages on OpenWHO in the First Quarter of 2020: Analysis of Platform Use Data |pdf=|usr=}}
| + | |
| − | {{tp|p=32017153|t=2020. Updates on Wuhan 2019 novel coronavirus epidemic |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| − | *'''[[Research tools]]''' | + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | + | |
| | + | *'''[[PrePrint scene]]''' |
| | + | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| − | *[lifechemicals.com antiviral candidate drugs]
| |
| − | *[biomol.com assays cytokines general spectrum]
| |
| − | *[labospace.com custom single probe assay 400 possible cytokines and so on]
| |
| − | *[codexdna.com dna synthesis]
| |
| − | *
| |
| | | | |
| | *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| | + | *'''[[on-topic personal thoughts]]''' |
